Am J Trop Med Hyg. 2012 Nov;87(5):796-805. doi: 10.4269/ajtmh.2012.12-0019. Epub 2012 Oct 1.
Dengue represents a substantial burden in many tropical and sub-tropical regions of the world. We estimated the economic burden of dengue illness in Malaysia. Information about economic burden is needed for setting health policy priorities, but accurate estimation is difficult because of incomplete data. We overcame this limitation by merging multiple data sources to refine our estimates, including an extensive literature review, discussion with experts, review of data from health and surveillance systems, and implementation of a Delphi process. Because Malaysia has a passive surveillance system, the number of dengue cases is under-reported. Using an adjusted estimate of total dengue cases, we estimated an economic burden of dengue illness of US$56 million (Malaysian Ringgit MYR196 million) per year, which is approximately US$2.03 (Malaysian Ringgit 7.14) per capita. The overall economic burden of dengue would be even higher if we included costs associated with dengue prevention and control, dengue surveillance, and long-term sequelae of dengue.
登革热在世界上许多热带和亚热带地区造成了巨大负担。我们估计了马来西亚登革热疾病的经济负担。为了确定卫生政策重点，需要了解有关经济负担的信息，但由于数据不完整，准确估计较为困难。我们通过合并多个数据源来克服这一限制，从而完善我们的估计，这些数据源包括广泛的文献综述、与专家的讨论、对卫生和监测系统数据的审查，以及德尔菲法的实施。由于马来西亚实行被动监测系统，因此登革热病例的报告数量不足。我们使用调整后的总登革热病例估计数，估计每年登革热疾病的经济负担为 5600 万美元（196 亿马来西亚林吉特），相当于每人 2.03 美元（7.14 马来西亚林吉特）。如果我们将与登革热预防和控制、登革热监测以及登革热的长期后遗症相关的成本也包括在内，那么登革热的总体经济负担将会更高。
